https://www.selleckchem.com/pr....oducts/elenestinib-p
Cholestasis may lead to hepatic cirrhosis and a longer hospital stay. A part of the patients with cholestasis requires liver transplantation. However, most of the treatment efficiency of cholestatic hepatitis (CH) is not satisfactory. For the patients with severe CH after artificial liver support, there was a lack of systemic evaluation on the treatment efficiency of double plasma molecular absorption system (DPMAS) for acute severe CH. We aim to investigate the treatment efficiency of DPMAS on acute severe CH. This retros
Like
Comment
Share
